135 related articles for article (PubMed ID: 38388144)
1. Anti-nephrin antibodies in recurrence of focal segmental glomerulosclerosis: closer to discovering the Holy Grail?
Vivarelli M; Colucci M
Kidney Int; 2024 Mar; 105(3):440-442. PubMed ID: 38388144
[TBL] [Abstract][Full Text] [Related]
2. Glomerular C4d deposition can precede the development of focal segmental glomerulosclerosis.
van de Lest NA; Zandbergen M; Wolterbeek R; Kreutz R; Trouw LA; Dorresteijn EM; Bruijn JA; Bajema IM; Scharpfenecker M; Chua JS
Kidney Int; 2019 Sep; 96(3):738-749. PubMed ID: 31327475
[TBL] [Abstract][Full Text] [Related]
3. A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence.
Shirai Y; Miura K; Ishizuka K; Ando T; Kanda S; Hashimoto J; Hamasaki Y; Hotta K; Ito N; Honda K; Tanabe K; Takano T; Hattori M
Kidney Int; 2024 Mar; 105(3):608-617. PubMed ID: 38110152
[TBL] [Abstract][Full Text] [Related]
4. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR
PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898
[TBL] [Abstract][Full Text] [Related]
5. Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation.
Shoji J; Mii A; Terasaki M; Shimizu A
Nephron; 2020; 144 Suppl 1():65-70. PubMed ID: 33260184
[TBL] [Abstract][Full Text] [Related]
6. Expression of nephrin in acquired forms of nephrotic syndrome in childhood.
Hingorani SR; Finn LS; Kowalewska J; McDonald RA; Eddy AA
Pediatr Nephrol; 2004 Mar; 19(3):300-5. PubMed ID: 14747939
[TBL] [Abstract][Full Text] [Related]
7. The nonspecificity of focal segmental glomerulosclerosis. The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change.
McAdams AJ; Valentini RP; Welch TR
Medicine (Baltimore); 1997 Jan; 76(1):42-52. PubMed ID: 9064487
[TBL] [Abstract][Full Text] [Related]
8. [Minimal change disease and focal segmental glomerulosclerosis in children--histomorphometric comparative study with application to computer image analysis].
Danilewicz M; Wagrowska-Danilewicz M
Przegl Lek; 1996; 53(7):529-33. PubMed ID: 8975287
[TBL] [Abstract][Full Text] [Related]
9. Pre-transplant angiotensin receptor II type 1 antibodies and risk of post-transplant focal segmental glomerulosclerosis recurrence.
Mujtaba MA; Sharfuddin AA; Book BL; Goggins WC; Khalil AA; Mishler DP; Fridell JA; Yaqub MS; Taber TE
Clin Transplant; 2015 Jul; 29(7):606-11. PubMed ID: 25973696
[TBL] [Abstract][Full Text] [Related]
10. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.
Schwartz MM
Ren Fail; 2000 Nov; 22(6):663-84. PubMed ID: 11104157
[TBL] [Abstract][Full Text] [Related]
11. Two different pathways of glomerular enlargement in adults with focal and segmental glomerulosclerosis: a morphometric study.
Matsumae T; Fukuzaki M; Takebayashi S; Naito S
Am J Nephrol; 1998; 18(1):21-7. PubMed ID: 9481435
[TBL] [Abstract][Full Text] [Related]
12. Childhood minimal change disease and focal segmental glomerulosclerosis: a continuous spectrum of disease? Pathologic study of 33 cases with long-term follow-up.
Lichtig C; Ben-Izhak O; On A; Levy J; Allon U
Am J Nephrol; 1991; 11(4):325-31. PubMed ID: 1799192
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology.
Watts AJB; Keller KH; Lerner G; Rosales I; Collins AB; Sekulic M; Waikar SS; Chandraker A; Riella LV; Alexander MP; Troost JP; Chen J; Fermin D; Yee JL; Sampson MG; Beck LH; Henderson JM; Greka A; Rennke HG; Weins A
J Am Soc Nephrol; 2022 Jan; 33(1):238-252. PubMed ID: 34732507
[TBL] [Abstract][Full Text] [Related]
14. A quantitative analysis of the glomeruli in focal segmental glomerulosclerosis.
Suzuki J; Yoshikawa N; Nakamura H
Pediatr Nephrol; 1994 Aug; 8(4):416-9. PubMed ID: 7947029
[TBL] [Abstract][Full Text] [Related]
15. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
[TBL] [Abstract][Full Text] [Related]
16. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
17. Histopathological atlas of renal diseases: Minimal Change disease and focal glomerulosclerosis.
Ferrario F; Rastaldi MP
J Nephrol; 2005; 18(1):1-4. PubMed ID: 15772916
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological differences in focal segmental glomerulosclerosis depending on the accompanying pathophysiological conditions in renal allografts.
Taneda S; Honda K; Koike J; Ito N; Ishida H; Takagi T; Nagashima Y
Virchows Arch; 2023 Dec; 483(6):809-819. PubMed ID: 37980299
[TBL] [Abstract][Full Text] [Related]
19. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
Garin EH; Mu W; Arthur JM; Rivard CJ; Araya CE; Shimada M; Johnson RJ
Kidney Int; 2010 Aug; 78(3):296-302. PubMed ID: 20485332
[TBL] [Abstract][Full Text] [Related]
20. IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?
Brugnano R; Del Sordo R; Covarelli C; Gnappi E; Pasquali S
J Nephrol; 2016 Aug; 29(4):479-86. PubMed ID: 26842624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
